Avery Dennison enters the back half of August with analysts raising targets and institutions adding shares — yet the stock is down on the week and options traders are running slightly more defensive than usual.
The most interesting angle right now is the gap between what the Street is saying and what price action is delivering. Following Q2 results at the end of July, a cluster of banks lifted their targets. UBS moved to $225, JPMorgan raised to $190, and B of A pushed to $210 — all maintaining their positive ratings. Even Citigroup, the notable hold-out at Neutral, nudged its target to $186. That unanimity of upward revisions is unusual. Yet at $177.71, the stock is down 1.1% on the week and still trading well below every major target on the board. The mean target of $201.80 implies roughly 14% upside from here — a spread wide enough to suggest either the Street is too optimistic or the market is not yet convinced the Q2 strength is durable.
The positioning picture is consistent with that ambivalence. Short interest is a modest 3.4% of the free float — not a crowded trade by any measure. It has eased 4.3% over the past week, suggesting shorts are not pressing their bets into the recent weakness. Borrowing costs confirm the disinterest: the cost to borrow has fallen 22% over the week to just 0.43%, an already-low level. The lending pool is fully relaxed — availability runs at over 2,300% of current short interest, meaning shares to borrow are essentially unlimited. There is no squeeze pressure here, and no sign of a structural short thesis building. Options tell a similar story of mild rather than extreme caution. The put/call ratio has edged up to 1.27, modestly above its 20-day average of 1.14, but only 0.4 standard deviations away — well within normal range. Whatever hedging is happening is not aggressive.
The bull case rests on RFID-driven growth in the Solutions segment and the momentum in logistics and food and grocery sales, which ran up roughly 15% in Q2. The CVS partnership has reportedly generated double-digit year-over-year revenue growth. Against that, the bear case points to a Q3 EPS guidance cut — management guided $2.39 against a prior estimate of $2.51 — and softness in apparel volumes. The valuation picture has improved along with the stock's 10.8% gain over the past month: the P/E has expanded to 16.5x and price-to-book has climbed to 5.5x. The forward EPS growth factor is a genuine standout, ranking in the 83rd percentile, while EPS surprise history ranks in the 71st. The dividend factor scores at the 99th percentile — though the dividend history data in ORTEX appears dated to 2022 and should not be relied upon for current yield calculations. The short score of 36.8 sits in the lower third of the universe, reinforcing that this is not a name with elevated short-side pressure.
On the institutional side, the holder list is a familiar cast of large passive and active managers. BlackRock is the largest holder at 8.6% and added just over 100,000 shares last month. State Street added 290,000 shares in July, Columbia added 280,000, and Dimensional added 174,000. T. Rowe Price was the most active buyer among major holders, adding over 231,000 shares through June. These are not aggressive tactical adds, but the breadth of incremental buying across several respected active managers provides a stable demand backdrop. Close packaging peers had a rough week: IP fell 4.2%, SW fell 4.7%, and AMCR lost 3.2%. AVY's 1.1% decline looks relatively contained in that context.
The next scheduled catalyst is Q3 earnings on 21 October. After Q2, the stock gained 1.5% on the day and 4.1% over the five sessions that followed — a muted but positive reaction despite the guidance trim. How management characterises apparel volume trends and whether RFID momentum can offset that softness will be the central questions worth watching into that print.
See the live data behind this article on ORTEX.
Open AVY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
